Complex Regional Pain Syndrome Clinical Trials

Find Complex Regional Pain Syndrome Clinical Trials Near You

Study of the Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Transcranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profile, and good efficacy in the contexts where it has been the subject of dedicated research: neuropathic pain, fibromyalgia, and visceral pain. Few studies have focused on the application of tDCS in the context of complex regional pain syndrome (CRPS), which is a common condition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Major

• Clinically active or active complex regional pain syndrome (CRPS) with positive Budapest criteria

• Scintigraphy showing signs consistent with CRPS

• Being affiliated with or a beneficiary of a social security scheme

Locations
Other Locations
France
Polyclinique de l'Europe
RECRUITING
Saint-nazaire
Contact Information
Primary
Valentin Billard
vbillard@vivalto-sante.com
02 51 16 16 16
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2027-06
Participants
Target number of participants: 32
Treatments
Experimental: Patient group receiving tDCS stimulation
Progressive increase in stimulation intensity up to 2 mA, then continuation at a plateau for a total of 20 minutes, then a decrease in stimulation intensity for 30 seconds at the end of the session before an automatic stop.
Placebo_comparator: Patient group receiving tDCS placebo stimulation
Control group : The stimulation intensity is gradually increased up to 2 mA for 1 minute, then decreased to zero stimulation. A further increase in stimulation is programmed 10 minutes after the start of stimulation.
Sponsors
Leads: Polyclinique de l'Europe

This content was sourced from clinicaltrials.gov